EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Imaging Advances in Light Chain Amyloidosis

Miaoling Qiu iD, Kaini Shen, Hua Yang, Jun Wang, Jian Li iD

Diagnostics · 16.07.2026 · 16 (14) · 2225

DOI: 10.3390/diagnostics16142225 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 16.07.2026. Verfasst von Miaoling Qiu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Clinical Research Center for Rare Diseases, Sanming Project of Medicine in Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Light chain (AL) amyloidosis is a systemic disorder caused by plasma cell dyscrasia, with cardiac involvement being the primary determinant of prognosis. Survival outcomes vary significantly across disease stages. This heterogeneity underscores a critical need for early diagnosis, precise risk stratification, and response-adapted therapy. In this context, multimodality imaging has emerged as an indispensable non-invasive tool, providing crucial insights for clinical decision-making. This review synthesizes recent advances in the application of key imaging modalities—echocardiography, magnetic resonance imaging, and nuclear medicine imaging—for evaluating AL amyloidosis. We highlight how these techniques have shifted the paradigm from anatomical assessment to quantitative, multiparametric tissue characterization, ultimately guiding personalized patient management.

Schlagwörter

Stichwörter der Autor:innen

cardiac amyloidosisechocardiographyintegrating artificial intelligencelight chain amyloidosismagnetic resonance imagingmultimodal imagingnuclear medicine imaging

Autor:innen und Institutionen

  • Department of Hematology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China.
  • Shenzhen Clinical Research Center for Rare Diseases, Shenzhen 518053, China.
  • Department of Hematology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

ORCID-Profile: Miaoling Qiu, Jian Li

Förderung

  • Shenzhen Clinical Research Center for Rare Diseases
  • Sanming Project of Medicine in Shenzhen

Zitieren

APA

Qiu, M., Shen, K., Yang, H., Wang, J., & Li, J. (2026). Imaging Advances in Light Chain Amyloidosis. Diagnostics, 16(14), 2225. https://doi.org/10.3390/diagnostics16142225

Vancouver

Qiu M, Shen K, Yang H, Wang J, Li J. Imaging Advances in Light Chain Amyloidosis. Diagnostics. 2026;16(14):2225. doi:10.3390/diagnostics16142225

BibTeX
@article{Qiu2026,
  author = {Qiu, Miaoling and Shen, Kaini and Yang, Hua and Wang, Jun and Li, Jian},
  title = {Imaging Advances in Light Chain Amyloidosis},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {14},
  pages = {2225},
  doi = {10.3390/diagnostics16142225}
}
Kostenlos starten →